Amphastar Pharmaceuticals
AMPH
#5537
Rank
C$1.76 B
Marketcap
C$37.86
Share price
-1.56%
Change (1 day)
-39.27%
Change (1 year)

Operating Margin for Amphastar Pharmaceuticals (AMPH)

Operating Margin as of December 2025 (TTM): 22.25%

According to Amphastar Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 22.25%. At the end of 2024 the company had an Operating Margin of 25.93%.

Operating Margin history for Amphastar Pharmaceuticals from 2013 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202425.93%-2.51%
202326.59%14.35%
202223.26%20.99%
202119.22%1350.08%
20201.33%-92.91%
201918.68%-654.65%
2018-3.37%-747.75%
20170.52%-90.93%
20165.73%-239.14%
2015-4.12%-52.21%
2014-8.62%-214.97%
20137.50%-40.78%
201212.67%-147.01%
2011-26.94%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Marinus Pharmaceuticals
MRNS
-446.48%-2,106.65%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
-849.01%-3,915.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-69.66%-413.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Tonix Pharmaceuticals
TNXP
-931.69%-4,287.37%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.